Jan Homolak

Nov 21, 2024 | nature.com | Jan Homolak |Lisa A. Maier

Entacapone, a drug used in the treatment of Parkinson’s disease, disrupts gut microbial communities by sequestering iron, creating a competitive advantage for iron-scavenging microbes that often carry antimicrobial resistance and virulence genes.